ATOVAQUONE

ATOVAQUONE was reported 8240 times

ATOVAQUONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
1 IVTH NERVE PARALYSIS 42 0.1772
2 PHALANGEAL HYPOPLASIA 12 0.1690
3 TRANSPLANT ABSCESS 6 0.1304
4 ENCEPHALITIS PROTOZOAL 7 0.1250
5 HAEMOPHILUS BACTERAEMIA 6 0.1224
6 CUTANEOUS MUCORMYCOSIS 21 0.1141
7 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
8 CUTANEOUS MALACOPLAKIA 5 0.0980
9 ACANTHAMOEBA INFECTION 17 0.0904
10 HEPATIC AMOEBIASIS 6 0.0896
11 CAMPYLOBACTER TEST POSITIVE 6 0.0789
12 CUTANEOUS NOCARDIOSIS 9 0.0692
13 VOCAL CORD OPERATION 6 0.0638
14 MALACOPLAKIA 28 0.0611
15 DISSEMINATED TOXOPLASMOSIS 7 0.0583
16 PULMONARY NOCARDIOSIS 47 0.0570
17 SPONTANEOUS BACTERIAL PERITONITIS 12 0.0492
18 TOTAL LUNG CAPACITY INCREASED 13 0.0478
19 SCROTAL ULCER 11 0.0421
20 SUSPECTED DRUG-INDUCED LIVER INJURY 8 0.0400
21 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
22 NOCARDIOSIS 94 0.0367
23 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0362
24 CEREBELLAR STROKE 14 0.0358
25 CHEST WALL ABSCESS 7 0.0354
26 MORGANELLA INFECTION 10 0.0341
27 PENILE ULCERATION 11 0.0336
28 DEVICE RELATED BACTERAEMIA 10 0.0323
29 ACUTE PULMONARY HISTOPLASMOSIS 5 0.0314
30 BURKHOLDERIA CEPACIA COMPLEX INFECTION 8 0.0280
31 LEISHMANIASIS 8 0.0276
32 IGA NEPHROPATHY 45 0.0271
33 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 14 0.0268
34 CONGENITAL FOOT MALFORMATION 12 0.0264
35 CONGENITAL APLASIA 8 0.0257
36 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
37 FUNGAL PHARYNGITIS 5 0.0199
38 XANTHOPSIA 7 0.0190
39 ENTEROCOCCAL BACTERAEMIA 20 0.0189
40 HAEMOSIDEROSIS 5 0.0187
41 TOXOPLASMOSIS 20 0.0185
42 CEREBRAL TOXOPLASMOSIS 17 0.0182
43 PROTEUS INFECTION 13 0.0181
44 HUMAN HERPESVIRUS 8 INFECTION 11 0.0181
45 ANAEMIA MEGALOBLASTIC 8 0.0179
46 DISSEMINATED MUCORMYCOSIS 7 0.0178
47 MONOCLONAL IMMUNOGLOBULIN INCREASED 5 0.0175
48 ARTERIOVENOUS FISTULA THROMBOSIS 6 0.0173
49 FUSARIUM INFECTION 12 0.0171
50 WOUND INFECTION BACTERIAL 7 0.0169
51 CHYLOTHORAX 12 0.0166
52 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0165
53 PNEUMOCYSTIS JIROVECII PNEUMONIA 155 0.0154
54 VASOGENIC CEREBRAL OEDEMA 11 0.0153
55 LUNG TRANSPLANT REJECTION 10 0.0152
56 GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0146
57 EVANS SYNDROME 7 0.0142
58 CEREBRAL MASS EFFECT 5 0.0138
59 SYPHILIS 10 0.0138
60 MIXED LIVER INJURY 41 0.0136
61 GENERALISED BULLOUS FIXED DRUG ERUPTION 5 0.0134
62 DISSEMINATED CRYPTOCOCCOSIS 10 0.0132
63 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0130
64 JARISCH-HERXHEIMER REACTION 9 0.0126
65 ANAL ULCER 10 0.0122
66 VULVAL DISORDER 8 0.0121
67 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 60 0.0120
68 MARROW HYPERPLASIA 8 0.0117
69 IMMUNE RECONSTITUTION SYNDROME 15 0.0116
70 ACQUIRED IMMUNODEFICIENCY SYNDROME 6 0.0116
71 MUCORMYCOSIS 30 0.0115
72 PULMONARY MUCORMYCOSIS 6 0.0114
73 DELAYED GRAFT FUNCTION 8 0.0113
74 MYCOBACTERIAL INFECTION 19 0.0110
75 GRAFT VERSUS HOST DISEASE 79 0.0110
76 ENTEROCOCCAL INFECTION 53 0.0110
77 SYSTEMIC CANDIDA 25 0.0099
78 METHAEMOGLOBINAEMIA 23 0.0099
79 ENTEROCOCCAL SEPSIS 8 0.0099
80 MENINGITIS LISTERIA 5 0.0098
81 GENE MUTATION 19 0.0096
82 CYTOMEGALOVIRUS TEST POSITIVE 17 0.0095
83 THROMBOTIC MICROANGIOPATHY 90 0.0092
84 INFECTIOUS PLEURAL EFFUSION 14 0.0092
85 LICHENOID KERATOSIS 21 0.0092
86 PNEUMONIA FUNGAL 36 0.0091
87 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 54 0.0091
88 STAPHYLOCOCCAL SKIN INFECTION 11 0.0089
89 ENTEROBACTER INFECTION 15 0.0089
90 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
91 HEPATIC CYTOLYSIS 111 0.0087
92 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
93 KLEBSIELLA BACTERAEMIA 8 0.0084
94 DERMO-HYPODERMITIS 5 0.0084
95 KLEBSIELLA INFECTION 41 0.0081
96 VOCAL CORD PARALYSIS 14 0.0078
97 KLEBSIELLA TEST POSITIVE 5 0.0077
98 CYTOMEGALOVIRUS VIRAEMIA 34 0.0076
99 PNEUMOCYSTIS JIROVECI PNEUMONIA 17 0.0076
100 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
101 GASTROINTESTINAL INJURY 20 0.0074
102 STAPHYLOCOCCAL BACTERAEMIA 32 0.0074
103 GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0073
104 VIRAEMIA 10 0.0072
105 HYPOMANIA 26 0.0071
106 BONE MARROW TRANSPLANT 13 0.0068
107 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 51 0.0068
108 HISTOPLASMOSIS 12 0.0068
109 GRANULOMATOSIS WITH POLYANGIITIS 8 0.0066
110 BICYTOPENIA 13 0.0066
111 FEBRILE BONE MARROW APLASIA 28 0.0066
112 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 14 0.0066
113 ASPERGILLUS INFECTION 43 0.0065
114 PNEUMONIA KLEBSIELLA 12 0.0065
115 URINARY TRACT INFECTION ENTEROCOCCAL 6 0.0064
116 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
117 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 7 0.0062
118 CYTOKINE RELEASE SYNDROME 125 0.0062
119 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
120 DEMYELINATING POLYNEUROPATHY 6 0.0058
121 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 19 0.0057
122 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
123 ANAEMIA MACROCYTIC 12 0.0056
124 ESCHERICHIA BACTERAEMIA 13 0.0055
125 HEART TRANSPLANT 5 0.0055
126 PULMONARY SEPSIS 8 0.0055
127 LISTERIOSIS 6 0.0054
128 LYME DISEASE 18 0.0054
129 JAUNDICE CHOLESTATIC 19 0.0054
130 BLOOD PRESSURE SYSTOLIC ABNORMAL 13 0.0053
131 LUNG ABSCESS 11 0.0052
132 AGRANULOCYTOSIS 97 0.0052
133 VASCULAR PSEUDOANEURYSM 9 0.0052
134 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
135 BRAIN ABSCESS 13 0.0051
136 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
137 HISTOPLASMOSIS DISSEMINATED 8 0.0050
138 PNEUMOMEDIASTINUM 9 0.0050
139 LUNG OPACITY 13 0.0049
140 ORAL MUCOSA EROSION 6 0.0049
141 STERNAL FRACTURE 6 0.0049
142 CORONAVIRUS TEST POSITIVE 5 0.0049
143 ADENOVIRUS INFECTION 14 0.0048
144 HEART TRANSPLANT REJECTION 5 0.0048
145 CYTOPENIA 58 0.0047
146 LEUKAEMIA RECURRENT 8 0.0047
147 RASH MORBILLIFORM 13 0.0047
148 STEROID DIABETES 7 0.0047
149 ORGANISING PNEUMONIA 23 0.0046
150 BACTERAEMIA 55 0.0046
151 CYTOMEGALOVIRUS INFECTION REACTIVATION 20 0.0045
152 FUNGAEMIA 7 0.0044
153 INFECTION REACTIVATION 5 0.0044
154 CENTRAL NERVOUS SYSTEM LYMPHOMA 6 0.0044
155 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0043
156 DYSLEXIA 5 0.0043
157 TOXIC EPIDERMAL NECROLYSIS 65 0.0043
158 ESCHERICHIA INFECTION 35 0.0043
159 OPTIC NEUROPATHY 9 0.0042
160 ENCEPHALOPATHY 104 0.0042
161 ACUTE MYELOID LEUKAEMIA RECURRENT 9 0.0042
162 VARICELLA 10 0.0042
163 HYPERURICAEMIA 17 0.0041
164 TONGUE COATED 7 0.0041
165 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
166 HYPERBILIRUBINAEMIA 42 0.0041
167 PNEUMONIA PNEUMOCOCCAL 6 0.0040
168 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
169 OESOPHAGEAL CANDIDIASIS 16 0.0040
170 SPLENIC INFARCTION 7 0.0040
171 PERSECUTORY DELUSION 10 0.0040
172 MENINGITIS CRYPTOCOCCAL 7 0.0040
173 FANCONI SYNDROME ACQUIRED 7 0.0040
174 LUNG TRANSPLANT 14 0.0040
175 IMMUNE-MEDIATED HEPATITIS 8 0.0039
176 CYTOMEGALOVIRUS INFECTION 65 0.0039
177 CALCULUS URINARY 6 0.0039
178 MYELITIS 6 0.0039
179 PNEUMONIA BACTERIAL 35 0.0038
180 RESPIRATORY SYNCYTIAL VIRUS INFECTION 33 0.0038
181 MYOPIA 9 0.0038
182 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 29 0.0037
183 FEBRILE NEUTROPENIA 247 0.0037
184 PANCYTOPENIA 208 0.0037
185 BRONCHIECTASIS 25 0.0037
186 CRYPTOCOCCOSIS 6 0.0037
187 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
188 VACCINATION FAILURE 6 0.0036
189 RHINOVIRUS INFECTION 14 0.0036
190 RHINITIS ALLERGIC 16 0.0036
191 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
192 BRAIN DEATH 11 0.0036
193 KIDNEY TRANSPLANT REJECTION 17 0.0035
194 ATYPICAL MYCOBACTERIAL INFECTION 5 0.0035
195 B-CELL LYMPHOMA 12 0.0035
196 GLOMERULAR FILTRATION RATE ABNORMAL 5 0.0035
197 CATAPLEXY 5 0.0035
198 READING DISORDER 8 0.0035
199 RASH MACULO-PAPULAR 77 0.0035
200 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
201 EXTREMITY NECROSIS 6 0.0034
202 COVID-19 PNEUMONIA 39 0.0033
203 SOFT TISSUE INFECTION 6 0.0033
204 BK VIRUS INFECTION 11 0.0033
205 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
206 PARTIAL SEIZURES 17 0.0032
207 TRANSPLANT REJECTION 26 0.0032
208 OTOTOXICITY 6 0.0032
209 CHOLESTASIS 62 0.0032
210 VENOOCCLUSIVE DISEASE 8 0.0032
211 DRUG RESISTANCE 82 0.0032
212 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
213 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
214 FAILURE TO THRIVE 16 0.0031
215 SERUM FERRITIN INCREASED 16 0.0030
216 ACUTE MYELOID LEUKAEMIA 47 0.0030
217 ACUTE RESPIRATORY FAILURE 57 0.0030
218 SCHIZOPHRENIA 36 0.0030
219 SARCOIDOSIS 14 0.0029
220 CLOSTRIDIUM DIFFICILE COLITIS 31 0.0029
221 VARICELLA ZOSTER VIRUS INFECTION 6 0.0029
222 HYPOGAMMAGLOBULINAEMIA 19 0.0029
223 BREAST DISCHARGE 5 0.0029
224 NASAL POLYPS 14 0.0028
225 ACUTE GRAFT VERSUS HOST DISEASE 13 0.0028
226 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
227 HYPERVOLAEMIA 14 0.0028
228 ABSCESS LIMB 12 0.0028
229 RESPIRATORY FAILURE 202 0.0028
230 CHRONIC GRAFT VERSUS HOST DISEASE 10 0.0028
231 URINARY TRACT INFECTION BACTERIAL 7 0.0028
232 DRUG ERUPTION 49 0.0028
233 SEPTIC SHOCK 120 0.0028
234 BLOOD HIV RNA INCREASED 5 0.0028
235 RENAL TUBULAR ACIDOSIS 6 0.0027
236 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
237 CUTANEOUS VASCULITIS 10 0.0027
238 ENDOMETRIAL CANCER 6 0.0027
239 CLOSTRIDIUM TEST POSITIVE 6 0.0027
240 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 70 0.0027
241 RETROPERITONEAL HAEMATOMA 6 0.0027
242 CHOLESTATIC LIVER INJURY 6 0.0027
243 DUODENAL ULCER 19 0.0027
244 DRUG LEVEL INCREASED 44 0.0027
245 HIV INFECTION 8 0.0027
246 VASCULAR DEVICE INFECTION 12 0.0026
247 PROTEIN TOTAL INCREASED 7 0.0026
248 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
249 HAEMOLYSIS 20 0.0026
250 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
251 ANHEDONIA 68 0.0026
252 ECONOMIC PROBLEM 39 0.0026
253 OESOPHAGITIS 28 0.0026
254 PATHOGEN RESISTANCE 23 0.0025
255 EMPYEMA 5 0.0025
256 PNEUMONIA VIRAL 8 0.0025
257 ANORECTAL DISORDER 5 0.0025
258 APLASTIC ANAEMIA 13 0.0025
259 PLASMA CELL MYELOMA RECURRENT 8 0.0025
260 MULTIPLE ORGAN DYSFUNCTION SYNDROME 69 0.0024
261 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
262 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
263 CAPILLARY LEAK SYNDROME 5 0.0024
264 HEPATIC ENZYME ABNORMAL 12 0.0024
265 THROMBOCYTOPENIA 269 0.0024
266 STEM CELL TRANSPLANT 6 0.0024
267 IMMUNOSUPPRESSION 21 0.0024
268 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
269 ATYPICAL PNEUMONIA 7 0.0023
270 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
271 SHOCK HAEMORRHAGIC 19 0.0023
272 PSEUDOMONAS INFECTION 20 0.0023
273 PHYSICAL DECONDITIONING 6 0.0023
274 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 6 0.0023
275 ACUTE RESPIRATORY DISTRESS SYNDROME 41 0.0023
276 CANDIDA INFECTION 39 0.0023
277 PORTAL HYPERTENSION 7 0.0023
278 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
279 HEPATOTOXICITY 50 0.0022
280 RENAL TUBULAR NECROSIS 22 0.0022
281 BACTERIAL TEST POSITIVE 5 0.0022
282 RENAL TRANSPLANT 8 0.0022
283 ODYNOPHAGIA 13 0.0022
284 OSTEOPENIA 33 0.0022
285 CYTOMEGALOVIRUS COLITIS 5 0.0022
286 LUNG INFILTRATION 19 0.0021
287 BILIRUBIN CONJUGATED INCREASED 5 0.0021
288 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
289 LUNG NEOPLASM 9 0.0021
290 MENINGITIS 14 0.0021
291 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
292 RETINAL VEIN OCCLUSION 6 0.0021
293 RALES 12 0.0021
294 NEUTROPENIA 279 0.0020
295 HAEMATOLOGICAL INFECTION 5 0.0020
296 COLITIS 77 0.0020
297 BONE MARROW FAILURE 41 0.0020
298 HAEMOLYTIC ANAEMIA 18 0.0020
299 NEUTROPHIL COUNT DECREASED 81 0.0020
300 THROMBOTIC THROMBOCYTOPENIC PURPURA 7 0.0020
301 LYMPHOPENIA 28 0.0020
302 END STAGE RENAL DISEASE 36 0.0020
303 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
304 DIASTOLIC DYSFUNCTION 6 0.0019
305 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 16 0.0019
306 INVESTIGATION 6 0.0019
307 ACUTE KIDNEY INJURY 292 0.0019
308 CHRONIC LYMPHOCYTIC LEUKAEMIA 9 0.0019
309 AMYLASE INCREASED 7 0.0019
310 BLOOD BILIRUBIN INCREASED 51 0.0019
311 GASTROINTESTINAL STROMAL TUMOUR 5 0.0019
312 CARDIAC DYSFUNCTION 7 0.0019
313 STEVENS-JOHNSON SYNDROME 41 0.0018
314 HYPERKALAEMIA 64 0.0018
315 PLASMA CELL MYELOMA 71 0.0018
316 TUMOUR LYSIS SYNDROME 16 0.0018
317 STAPHYLOCOCCAL INFECTION 59 0.0018
318 ENDOTRACHEAL INTUBATION 5 0.0018
319 CHOLANGITIS 11 0.0018
320 HEPATIC FUNCTION ABNORMAL 66 0.0018
321 LEUKOCYTOSIS 32 0.0018
322 HYPOPHOSPHATAEMIA 13 0.0018
323 SKIN PAPILLOMA 7 0.0017
324 CYSTITIS HAEMORRHAGIC 7 0.0017
325 HYPOXIA 61 0.0017
326 NEPHROGENIC ANAEMIA 8 0.0017
327 RENAL FUNCTION TEST ABNORMAL 8 0.0017
328 GASTRITIS EROSIVE 8 0.0017
329 SEPSIS 191 0.0017
330 ERYTHEMA NODOSUM 6 0.0017
331 PAPULE 12 0.0017
332 HERPES SIMPLEX 11 0.0017
333 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
334 PLATELET COUNT DECREASED 179 0.0017
335 RECALLED PRODUCT ADMINISTERED 16 0.0017
336 HYPERLIPIDAEMIA 20 0.0017
337 ANAL ABSCESS 9 0.0017
338 HYPERCAPNIA 5 0.0017
339 DRUG-INDUCED LIVER INJURY 52 0.0017
340 BONE MARROW DISORDER 5 0.0017
341 LIVER TRANSPLANT 6 0.0016
342 CHOLELITHIASIS 54 0.0016
343 STAPHYLOCOCCAL SEPSIS 8 0.0016
344 CARDIAC MURMUR 14 0.0016
345 CHEMOTHERAPY 6 0.0016
346 PARANASAL SINUS DISCOMFORT 6 0.0016
347 ABDOMINAL ABSCESS 7 0.0016
348 DYSLIPIDAEMIA 8 0.0016
349 BRAIN NEOPLASM MALIGNANT 7 0.0016
350 ENTEROCOLITIS 9 0.0016
351 IRON DEFICIENCY 7 0.0016
352 PULMONARY TOXICITY 11 0.0016
353 SUSPECTED OFF LABEL USE 7 0.0015
354 LIVER ABSCESS 5 0.0015
355 DISEASE COMPLICATION 7 0.0015
356 IMMUNE THROMBOCYTOPENIA 7 0.0015
357 BLOOD LACTIC ACID INCREASED 8 0.0015
358 PNEUMONITIS 41 0.0015
359 DIARRHOEA HAEMORRHAGIC 14 0.0015
360 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
361 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
362 ELECTROLYTE IMBALANCE 17 0.0015
363 FAECALOMA 8 0.0015
364 HEPATIC FAILURE 44 0.0015
365 LEUKOPENIA 73 0.0015
366 APLASIA PURE RED CELL 5 0.0015
367 PLEURAL EFFUSION 88 0.0014
368 INTERSTITIAL LUNG DISEASE 70 0.0014
369 HYPERTHERMIA 11 0.0014
370 NECROSIS 8 0.0014
371 SHOCK 33 0.0014
372 APHTHOUS ULCER 11 0.0014
373 LYMPHOCYTE COUNT DECREASED 25 0.0014
374 HYPOPHAGIA 36 0.0014
375 ISCHAEMIC STROKE 25 0.0014
376 HAEMOGLOBIN ABNORMAL 9 0.0014
377 BACTERIAL INFECTION 26 0.0014
378 MOUTH ULCERATION 29 0.0014
379 HYPOCALCAEMIA 26 0.0014
380 RASH PUSTULAR 10 0.0014
381 PULMONARY FUNCTION TEST DECREASED 6 0.0014
382 EOSINOPHILIA 24 0.0014
383 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75 0.0014
384 CEREBRAL DISORDER 10 0.0014
385 SKIN NECROSIS 7 0.0013
386 SKIN MASS 9 0.0013
387 QUALITY OF LIFE DECREASED 18 0.0013
388 PERICARDIAL EFFUSION 31 0.0013
389 FULL BLOOD COUNT DECREASED 27 0.0013
390 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
391 NEPHROPATHY TOXIC 15 0.0013
392 HYDRONEPHROSIS 10 0.0013
393 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
394 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
395 CATHETER SITE INFECTION 5 0.0013
396 MYELODYSPLASTIC SYNDROME 19 0.0013
397 PYREXIA 453 0.0013
398 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
399 GINGIVITIS 7 0.0013
400 AUTOIMMUNE HEPATITIS 9 0.0013
401 TOXIC SKIN ERUPTION 13 0.0013
402 HYPOALBUMINAEMIA 10 0.0013
403 DRUG LEVEL DECREASED 13 0.0013
404 ALANINE AMINOTRANSFERASE INCREASED 78 0.0013
405 JAUNDICE 34 0.0013
406 RED BLOOD CELL COUNT DECREASED 36 0.0013
407 NEUROTOXICITY 22 0.0013
408 CANDIDIASIS 5 0.0012
409 ATELECTASIS 12 0.0012
410 SKIN LESION 34 0.0012
411 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
412 HEPATITIS ACUTE 8 0.0012
413 INCORRECT DOSAGE ADMINISTERED 6 0.0012
414 MYOSITIS 11 0.0012
415 ARTHRITIS BACTERIAL 5 0.0012
416 PNEUMONIA 393 0.0012
417 LEG AMPUTATION 5 0.0012
418 SPINAL COMPRESSION FRACTURE 10 0.0012
419 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
420 METABOLIC DISORDER 7 0.0012
421 PROTEIN URINE PRESENT 6 0.0012
422 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
423 RENAL FAILURE 158 0.0012
424 ENDOCARDITIS 6 0.0012
425 LEUKAEMIA 11 0.0012
426 GASTROENTERITIS 17 0.0012
427 HEPATITIS CHOLESTATIC 7 0.0012
428 MYOPATHY 10 0.0012
429 PANCREATITIS ACUTE 26 0.0012
430 ASCITES 34 0.0012
431 ENCEPHALITIS 8 0.0012
432 PYELONEPHRITIS 10 0.0012
433 ADRENAL INSUFFICIENCY 14 0.0012
434 DERMATITIS ACNEIFORM 7 0.0011
435 ASPARTATE AMINOTRANSFERASE INCREASED 61 0.0011
436 LIVER INJURY 28 0.0011
437 IMMUNODEFICIENCY 17 0.0011
438 BLOOD CREATININE INCREASED 74 0.0011
439 CELLULITIS 57 0.0011
440 HEPATOCELLULAR INJURY 16 0.0011
441 TRANSAMINASES INCREASED 25 0.0011
442 LUNG DISORDER 55 0.0011
443 STRESS FRACTURE 6 0.0011
444 RENAL IMPAIRMENT 93 0.0011
445 LIVER DISORDER 49 0.0011
446 HYPOKALAEMIA 51 0.0011
447 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
448 COVID-19 192 0.0011
449 ANAEMIA 208 0.0011
450 DYSPNOEA EXERTIONAL 41 0.0011
451 FUNGAL INFECTION 36 0.0011
452 HYPERGLYCAEMIA 39 0.0011
453 MUCOSAL INFLAMMATION 28 0.0011
454 ORAL CANDIDIASIS 14 0.0011
455 WHITE BLOOD CELL COUNT DECREASED 115 0.0011
456 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
457 BLOOD MAGNESIUM DECREASED 9 0.0010
458 DEVICE RELATED INFECTION 16 0.0010
459 OXYGEN SATURATION DECREASED 58 0.0010
460 HYPOVOLAEMIA 6 0.0010
461 HYPERTRIGLYCERIDAEMIA 6 0.0010
462 SPLENOMEGALY 12 0.0010
463 BONE DENSITY DECREASED 32 0.0010
464 DECREASED ACTIVITY 11 0.0010
465 BLOOD UREA INCREASED 17 0.0010
466 BLOOD ALBUMIN DECREASED 8 0.0010
467 PULMONARY MASS 15 0.0010
468 HYPERAMMONAEMIA 5 0.0010
469 OSTEOPOROSIS 41 0.0010
470 PLATELET COUNT ABNORMAL 6 0.0010
471 MALNUTRITION 11 0.0010
472 HEPATIC ENZYME INCREASED 67 0.0010
473 RESPIRATORY DISTRESS 27 0.0010
474 LIVER FUNCTION TEST INCREASED 21 0.0010
475 NEUTROPHIL COUNT INCREASED 10 0.0010
476 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
477 MENTAL STATUS CHANGES 27 0.0010
478 LYMPHOMA 15 0.0010
479 ERYTHEMA MULTIFORME 9 0.0010
480 FAECES SOFT 7 0.0010
481 PETECHIAE 10 0.0010
482 INTENTIONAL UNDERDOSE 7 0.0010
483 DRUG INTERACTION 152 0.0010
484 TACHYPNOEA 13 0.0010
485 OFF LABEL USE 836 0.0010
486 MELAENA 21 0.0010
487 CHRONIC KIDNEY DISEASE 72 0.0009
488 DISEASE RECURRENCE 45 0.0009
489 TREATMENT FAILURE 78 0.0009
490 TASTE DISORDER 19 0.0009
491 MULTI-ORGAN FAILURE 16 0.0009
492 BLOOD POTASSIUM INCREASED 15 0.0009
493 CHILLS 108 0.0009
494 RENAL FAILURE ACUTE 39 0.0009
495 CONDITION AGGRAVATED 279 0.0009
496 WOUND INFECTION 10 0.0009
497 MULTIPLE FRACTURES 15 0.0009
498 DYSGRAPHIA 6 0.0009
499 CORONAVIRUS INFECTION 6 0.0009
500 PURPURA 8 0.0009
501 HYPERCALCAEMIA 11 0.0009
502 ANAL INCONTINENCE 8 0.0009
503 HAEMOGLOBIN DECREASED 91 0.0009
504 REBOUND EFFECT 10 0.0009
505 ECCHYMOSIS 6 0.0009
506 RHINITIS 7 0.0009
507 UROSEPSIS 8 0.0009
508 BLOOD URIC ACID INCREASED 5 0.0009
509 BONE LOSS 13 0.0009
510 HYPERTRANSAMINASAEMIA 6 0.0009
511 DISEASE PROGRESSION 102 0.0009
512 HYPOMAGNESAEMIA 12 0.0009
513 DEEP VEIN THROMBOSIS 56 0.0009
514 TRANSFUSION 9 0.0009
515 BLOOD COUNT ABNORMAL 13 0.0009
516 NEPHROPATHY 8 0.0009
517 POLYURIA 7 0.0009
518 FULL BLOOD COUNT ABNORMAL 9 0.0009
519 SQUAMOUS CELL CARCINOMA 8 0.0008
520 SEASONAL ALLERGY 12 0.0008
521 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
522 DIALYSIS 12 0.0008
523 HERPES ZOSTER 48 0.0008
524 HEPATITIS B 5 0.0008
525 DERMATITIS BULLOUS 6 0.0008
526 HOSPICE CARE 8 0.0008
527 HAEMORRHAGE INTRACRANIAL 12 0.0008
528 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
529 C-REACTIVE PROTEIN INCREASED 29 0.0008
530 INFUSION SITE SWELLING 5 0.0008
531 RENAL DISORDER 37 0.0008
532 LIVER FUNCTION TEST ABNORMAL 23 0.0008
533 MUSCLE ATROPHY 10 0.0008
534 MYOCARDITIS 9 0.0008
535 LIPASE INCREASED 6 0.0008
536 HEPATITIS 20 0.0008
537 RENAL FAILURE CHRONIC 6 0.0008
538 GOUT 14 0.0008
539 OSTEOMYELITIS 14 0.0008
540 TENDERNESS 8 0.0008
541 PULMONARY HAEMORRHAGE 6 0.0008
542 TOOTH INFECTION 10 0.0008
543 NEUROPATHY PERIPHERAL 72 0.0008
544 PNEUMOTHORAX 12 0.0008
545 HAEMATOCRIT DECREASED 15 0.0008
546 HAEMOPTYSIS 21 0.0008
547 ATRIAL FLUTTER 6 0.0008
548 PRESCRIBED UNDERDOSE 15 0.0008
549 VIRAL INFECTION 25 0.0008
550 CARDIAC FAILURE ACUTE 5 0.0007
551 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
552 LOCALISED INFECTION 18 0.0007
553 BLOOD SODIUM DECREASED 14 0.0007
554 FEEDING DISORDER 15 0.0007
555 PRODUCT TASTE ABNORMAL 10 0.0007
556 DECUBITUS ULCER 6 0.0007
557 HAEMATOMA 19 0.0007
558 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
559 ASPIRATION 8 0.0007
560 ATRIAL FIBRILLATION 71 0.0007
561 APHASIA 22 0.0007
562 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
563 ACUTE CORONARY SYNDROME 6 0.0007
564 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
565 DIZZINESS POSTURAL 7 0.0007
566 PNEUMONIA ASPIRATION 18 0.0007
567 HAEMODIALYSIS 6 0.0007
568 PRODUCT USE IN UNAPPROVED INDICATION 177 0.0007
569 TREATMENT NONCOMPLIANCE 39 0.0007
570 INTESTINAL PERFORATION 8 0.0007
571 HEPATOMEGALY 7 0.0007
572 ABDOMINAL PAIN LOWER 18 0.0007
573 LABORATORY TEST ABNORMAL 21 0.0007
574 FACE OEDEMA 12 0.0007
575 PSYCHOTIC DISORDER 21 0.0007
576 HYPONATRAEMIA 40 0.0007
577 STOMATITIS 43 0.0007
578 INFECTION 102 0.0007
579 SINUS TACHYCARDIA 10 0.0007
580 SUBDURAL HAEMATOMA 10 0.0007
581 HEPATIC STEATOSIS 13 0.0007
582 SKIN ULCER 18 0.0007
583 DIPLOPIA 18 0.0007
584 PULMONARY OEDEMA 31 0.0007
585 METABOLIC ACIDOSIS 22 0.0007
586 TACHYCARDIA 61 0.0007
587 URINE OUTPUT DECREASED 6 0.0007
588 NIGHT SWEATS 22 0.0007
589 PULMONARY CONGESTION 9 0.0007
590 DIARRHOEA 437 0.0007
591 VENTRICULAR EXTRASYSTOLES 7 0.0007
592 BLOOD PRESSURE FLUCTUATION 16 0.0007
593 ACUTE HEPATIC FAILURE 9 0.0007
594 HAEMODYNAMIC INSTABILITY 5 0.0007
595 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
596 GRAND MAL CONVULSION 6 0.0006
597 SPINAL FRACTURE 13 0.0006
598 LACTIC ACIDOSIS 21 0.0006
599 GENERALISED OEDEMA 8 0.0006
600 ACUTE MYOCARDIAL INFARCTION 19 0.0006
601 HEPATIC ENCEPHALOPATHY 6 0.0006
602 PULMONARY THROMBOSIS 7 0.0006
603 THERAPY PARTIAL RESPONDER 10 0.0006
604 FLANK PAIN 6 0.0006
605 GASTROINTESTINAL INFLAMMATION 5 0.0006
606 DECREASED APPETITE 148 0.0006
607 BODY TEMPERATURE INCREASED 13 0.0006
608 RASH 277 0.0006
609 COUGH 178 0.0006
610 BRAIN OEDEMA 8 0.0006
611 PARALYSIS 9 0.0006
612 SENSORY DISTURBANCE 10 0.0006
613 INFUSION RELATED REACTION 41 0.0006
614 MITRAL VALVE INCOMPETENCE 7 0.0006
615 FLUID OVERLOAD 9 0.0006
616 AUTOIMMUNE DISORDER 6 0.0006
617 OEDEMA PERIPHERAL 75 0.0006
618 SCAB 7 0.0006
619 DEAFNESS 16 0.0006
620 MYELOSUPPRESSION 22 0.0006
621 OSTEONECROSIS 20 0.0006
622 GASTRITIS 16 0.0006
623 PRODUCTIVE COUGH 29 0.0006
624 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
625 HOSPITALISATION 93 0.0006
626 INABILITY TO AFFORD MEDICATION 6 0.0006
627 BLOOD PRESSURE ABNORMAL 12 0.0006
628 EMOTIONAL DISTRESS 73 0.0006
629 VASCULITIS 7 0.0006
630 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
631 BRAIN INJURY 6 0.0006
632 HEART RATE DECREASED 21 0.0006
633 GENERAL PHYSICAL HEALTH DETERIORATION 69 0.0006
634 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
635 HYPOTENSION 119 0.0006
636 SINUS CONGESTION 8 0.0006
637 INSURANCE ISSUE 9 0.0006
638 EPISTAXIS 44 0.0006
639 FRACTURE 11 0.0006
640 VOMITING 273 0.0006
641 FOOT FRACTURE 11 0.0006
642 EJECTION FRACTION DECREASED 9 0.0006
643 PULMONARY HYPERTENSION 12 0.0006
644 RESPIRATORY TRACT INFECTION 15 0.0006
645 MASS 8 0.0006
646 FOLLICULITIS 6 0.0006
647 BLOOD TEST ABNORMAL 8 0.0006
648 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
649 BLOOD POTASSIUM DECREASED 17 0.0006
650 ILEUS 7 0.0006
651 DEHYDRATION 75 0.0006
652 CARDIOGENIC SHOCK 8 0.0006
653 DERMATITIS ALLERGIC 7 0.0006
654 SKIN LACERATION 6 0.0006
655 PRODUCT PRESCRIBING ISSUE 12 0.0006
656 GASTROINTESTINAL HAEMORRHAGE 46 0.0005
657 NEPHROLITHIASIS 25 0.0005
658 IRON DEFICIENCY ANAEMIA 5 0.0005
659 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
660 CONSTIPATION 117 0.0005
661 SKIN INFECTION 6 0.0005
662 RIB FRACTURE 11 0.0005
663 OEDEMA 29 0.0005
664 PRESYNCOPE 13 0.0005
665 EYE INFECTION 6 0.0005
666 PANCREATITIS 28 0.0005
667 DYSPNOEA 299 0.0005
668 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
669 RHABDOMYOLYSIS 22 0.0005
670 PRODUCT AVAILABILITY ISSUE 12 0.0005
671 CONTUSION 50 0.0005
672 DRUG INTOLERANCE 50 0.0005
673 NAUSEA 408 0.0005
674 IMPAIRED GASTRIC EMPTYING 7 0.0005
675 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
676 VISUAL ACUITY REDUCED 17 0.0005
677 BODY TEMPERATURE DECREASED 5 0.0005
678 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
679 BLOOD IRON DECREASED 6 0.0005
680 DIVERTICULITIS 14 0.0005
681 GALLBLADDER DISORDER 9 0.0005
682 CHOLECYSTITIS 6 0.0005
683 RESPIRATORY TRACT CONGESTION 8 0.0005
684 MYOCLONUS 6 0.0005
685 PREMATURE DELIVERY 8 0.0005
686 INFLUENZA 56 0.0005
687 WRIST FRACTURE 6 0.0005
688 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
689 BLOOD PRESSURE INCREASED 76 0.0005
690 HAEMATURIA 17 0.0005
691 BONE DISORDER 9 0.0005
692 MOTOR DYSFUNCTION 5 0.0005
693 CARDIOMEGALY 6 0.0005
694 CHROMATURIA 11 0.0005
695 PULMONARY EMBOLISM 46 0.0005
696 PHARYNGITIS 6 0.0005
697 EYE DISCHARGE 5 0.0005
698 RASH ERYTHEMATOUS 23 0.0005
699 COAGULOPATHY 8 0.0005
700 ASTHENIA 180 0.0005
701 BONE PAIN 28 0.0005
702 BLOOD URINE PRESENT 9 0.0005
703 FLUID RETENTION 24 0.0005
704 LOWER LIMB FRACTURE 9 0.0005
705 HYPERTENSION 99 0.0005
706 INFUSION SITE PAIN 6 0.0005
707 RECTAL HAEMORRHAGE 20 0.0005
708 ERUCTATION 9 0.0005
709 PRESCRIBED OVERDOSE 9 0.0005
710 DYSPHAGIA 44 0.0005
711 HAEMORRHOIDS 9 0.0005
712 CARDIAC FAILURE 37 0.0005
713 IMMUNE SYSTEM DISORDER 6 0.0005
714 CARDIO-RESPIRATORY ARREST 19 0.0005
715 SARS-COV-2 TEST POSITIVE 6 0.0005
716 HEART RATE INCREASED 45 0.0005
717 CHEST PAIN 84 0.0005
718 NEURALGIA 11 0.0005
719 EAR INFECTION 12 0.0005
720 LUNG INFECTION 7 0.0005
721 CEREBRAL INFARCTION 11 0.0004
722 CARDIAC ARREST 37 0.0004
723 BRAIN FOG 7 0.0004
724 GASTROINTESTINAL DISORDER 40 0.0004
725 BRONCHITIS 33 0.0004
726 INFLAMMATION 23 0.0004
727 THERAPY NON-RESPONDER 20 0.0004
728 GASTROENTERITIS VIRAL 8 0.0004
729 RASH PRURITIC 24 0.0004
730 UVEITIS 6 0.0004
731 URINARY TRACT INFECTION 75 0.0004
732 ABSCESS 7 0.0004
733 MICTURITION URGENCY 5 0.0004
734 RHINORRHOEA 28 0.0004
735 MUSCULAR WEAKNESS 49 0.0004
736 DYSGEUSIA 32 0.0004
737 APHONIA 6 0.0004
738 SKIN REACTION 6 0.0004
739 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
740 ABDOMINAL DISTENSION 44 0.0004
741 DRY EYE 21 0.0004
742 PRODUCT PRESCRIBING ERROR 10 0.0004
743 SKIN DISORDER 14 0.0004
744 WEIGHT DECREASED 117 0.0004
745 HAEMATOCHEZIA 23 0.0004
746 PARAESTHESIA ORAL 6 0.0004
747 FAECES DISCOLOURED 9 0.0004
748 CONFUSIONAL STATE 67 0.0004
749 SKIN DISCOLOURATION 19 0.0004
750 DYSSTASIA 12 0.0004
751 ABDOMINAL PAIN 95 0.0004
752 ANXIETY 116 0.0004
753 CARDIOMYOPATHY 6 0.0004
754 WHEEZING 24 0.0004
755 FATIGUE 314 0.0004
756 ORTHOSTATIC HYPOTENSION 7 0.0004
757 ORAL PAIN 9 0.0004
758 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
759 RESPIRATORY DISORDER 12 0.0004
760 LETHARGY 23 0.0004
761 OROPHARYNGEAL PAIN 37 0.0004
762 AMNESIA 26 0.0004
763 LYMPHADENOPATHY 14 0.0004
764 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
765 DYSPHONIA 23 0.0004
766 TOXICITY TO VARIOUS AGENTS 66 0.0004
767 THERAPY CESSATION 20 0.0004
768 ABDOMINAL DISCOMFORT 65 0.0004
769 RASH GENERALISED 10 0.0004
770 TOOTH LOSS 8 0.0004
771 HYPERSOMNIA 11 0.0004
772 RESTLESSNESS 14 0.0004
773 CYANOSIS 6 0.0004
774 DIABETES MELLITUS 29 0.0004
775 ANKYLOSING SPONDYLITIS 5 0.0004
776 ABDOMINAL PAIN UPPER 78 0.0004
777 PALPITATIONS 44 0.0004
778 DEATH 323 0.0004
779 MIDDLE INSOMNIA 7 0.0004
780 DELIRIUM 13 0.0004
781 IMPAIRED WORK ABILITY 8 0.0004
782 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
783 SKIN CANCER 8 0.0004
784 CHEST DISCOMFORT 38 0.0004
785 LIMB INJURY 10 0.0004
786 LUNG NEOPLASM MALIGNANT 15 0.0004
787 POST PROCEDURAL COMPLICATION 7 0.0004
788 PERIPHERAL SWELLING 56 0.0004
789 NEOPLASM MALIGNANT 24 0.0004
790 ILLNESS 37 0.0004
791 ORAL HERPES 7 0.0004
792 PERICARDITIS 6 0.0004
793 PRODUCT DOSE OMISSION ISSUE 105 0.0004
794 RASH PAPULAR 8 0.0004
795 FOETAL EXPOSURE DURING PREGNANCY 29 0.0004
796 KIDNEY INFECTION 7 0.0004
797 TYPE 2 DIABETES MELLITUS 12 0.0004
798 DISABILITY 7 0.0004
799 BACK PAIN 82 0.0004
800 UPPER LIMB FRACTURE 7 0.0004
801 HYPOGLYCAEMIA 17 0.0004
802 VISION BLURRED 48 0.0003
803 PARANOIA 6 0.0003
804 MATERNAL EXPOSURE DURING PREGNANCY 31 0.0003
805 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
806 HYPERTHYROIDISM 5 0.0003
807 DRY MOUTH 28 0.0003
808 SWELLING 32 0.0003
809 SINUSITIS 35 0.0003
810 NASAL CONGESTION 20 0.0003
811 TREMOR 56 0.0003
812 PRODUCT USE ISSUE 63 0.0003
813 CEREBRAL HAEMORRHAGE 12 0.0003
814 THROAT TIGHTNESS 9 0.0003
815 HALLUCINATION 25 0.0003
816 HALLUCINATION, VISUAL 7 0.0003
817 TOOTHACHE 6 0.0003
818 URINARY RETENTION 11 0.0003
819 SEIZURE 38 0.0003
820 EATING DISORDER 7 0.0003
821 EPILEPSY 10 0.0003
822 DRUG INEFFECTIVE 429 0.0003
823 BLOOD GLUCOSE ABNORMAL 6 0.0003
824 OSTEONECROSIS OF JAW 8 0.0003
825 PAIN 198 0.0003
826 BLISTER 18 0.0003
827 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
828 PHOTOPHOBIA 6 0.0003
829 DYSARTHRIA 12 0.0003
830 PAIN IN JAW 9 0.0003
831 HAEMATEMESIS 8 0.0003
832 TOOTH DISORDER 7 0.0003
833 CYSTITIS 10 0.0003
834 HYPERSENSITIVITY 58 0.0003
835 THROAT IRRITATION 14 0.0003
836 MUSCLE SPASMS 57 0.0003
837 DIZZINESS 152 0.0003
838 UNEVALUABLE EVENT 23 0.0003
839 URINARY INCONTINENCE 9 0.0003
840 INFLUENZA LIKE ILLNESS 25 0.0003
841 CATARACT 18 0.0003
842 BALANCE DISORDER 26 0.0003
843 CARDIAC FAILURE CONGESTIVE 24 0.0003
844 THROMBOSIS 24 0.0003
845 HEADACHE 187 0.0003
846 THERAPY INTERRUPTED 21 0.0003
847 COLITIS ULCERATIVE 13 0.0003
848 NERVOUS SYSTEM DISORDER 9 0.0003
849 POLLAKIURIA 12 0.0003
850 GAIT DISTURBANCE 55 0.0003
851 LOCAL SWELLING 5 0.0003
852 DERMATITIS 6 0.0003
853 NECK PAIN 16 0.0003
854 BLOOD PRESSURE DECREASED 19 0.0003
855 MALAISE 125 0.0003
856 EYE PAIN 16 0.0003
857 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
858 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
859 TINNITUS 13 0.0003
860 INSOMNIA 75 0.0003
861 AGEUSIA 7 0.0003
862 THERAPEUTIC RESPONSE DECREASED 17 0.0003
863 ILL-DEFINED DISORDER 17 0.0003
864 DISORIENTATION 11 0.0003
865 VAGINAL HAEMORRHAGE 12 0.0003
866 MENTAL DISORDER 12 0.0003
867 ACCIDENTAL OVERDOSE 10 0.0003
868 PRURITUS 105 0.0003
869 ANAPHYLACTIC SHOCK 7 0.0003
870 UNRESPONSIVE TO STIMULI 7 0.0003
871 BURNING SENSATION 19 0.0003
872 LIP SWELLING 9 0.0003
873 BLINDNESS 11 0.0003
874 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
875 RENAL INJURY 8 0.0003
876 NASOPHARYNGITIS 49 0.0003
877 MYALGIA 45 0.0003
878 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
879 BRADYCARDIA 14 0.0003
880 URTICARIA 44 0.0003
881 ADVERSE EVENT 24 0.0003
882 OSTEOARTHRITIS 11 0.0003
883 RASH MACULAR 9 0.0003
884 EAR PAIN 5 0.0003
885 JOINT SWELLING 31 0.0003
886 WEIGHT INCREASED 57 0.0003
887 ERYTHEMA 52 0.0003
888 PROCEDURAL PAIN 7 0.0003
889 FEELING COLD 7 0.0003
890 HYPOTHYROIDISM 8 0.0003
891 HIP FRACTURE 8 0.0002
892 HYPOAESTHESIA 37 0.0002
893 PANIC ATTACK 9 0.0002
894 FLATULENCE 14 0.0002
895 SWELLING FACE 16 0.0002
896 DYSURIA 9 0.0002
897 DYSPEPSIA 24 0.0002
898 EYE SWELLING 9 0.0002
899 EXPOSURE DURING PREGNANCY 15 0.0002
900 INTESTINAL OBSTRUCTION 9 0.0002
901 PAIN IN EXTREMITY 70 0.0002
902 BLOOD CHOLESTEROL INCREASED 11 0.0002
903 COGNITIVE DISORDER 11 0.0002
904 ANAPHYLACTIC REACTION 13 0.0002
905 ADVERSE DRUG REACTION 21 0.0002
906 GASTRIC DISORDER 8 0.0002
907 ARRHYTHMIA 11 0.0002
908 ECZEMA 12 0.0002
909 SPEECH DISORDER 12 0.0002
910 FEMUR FRACTURE 7 0.0002
911 FALL 75 0.0002
912 GLOSSODYNIA 5 0.0002
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
914 ARTHRALGIA 92 0.0002
915 SYNCOPE 22 0.0002
916 LOSS OF CONSCIOUSNESS 28 0.0002
917 MOVEMENT DISORDER 7 0.0002
918 HYPERHIDROSIS 28 0.0002
919 MEDICATION ERROR 12 0.0002
920 WOUND 6 0.0002
921 SKIN EXFOLIATION 18 0.0002
922 VERTIGO 13 0.0002
923 FEELING HOT 13 0.0002
924 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
925 OCULAR HYPERAEMIA 10 0.0002
926 EYE PRURITUS 7 0.0002
927 DEPRESSION 47 0.0002
928 ABASIA 5 0.0002
929 PREMATURE BABY 6 0.0002
930 PRODUCT DOSE OMISSION 13 0.0002
931 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
932 DISCOMFORT 12 0.0002
933 DRY SKIN 26 0.0002
934 SOMNOLENCE 39 0.0002
935 ROAD TRAFFIC ACCIDENT 8 0.0002
936 MUSCULOSKELETAL PAIN 10 0.0002
937 ARTHRITIS 15 0.0002
938 JOINT STIFFNESS 5 0.0002
939 MOOD SWINGS 6 0.0002
940 DISTURBANCE IN ATTENTION 10 0.0002
941 SLEEP DISORDER 13 0.0002
942 ARTHROPATHY 10 0.0002
943 VISUAL IMPAIRMENT 22 0.0002
944 AGITATION 13 0.0002
945 INTENTIONAL DOSE OMISSION 5 0.0002
946 CONVULSION 10 0.0002
947 NEOPLASM PROGRESSION 6 0.0002
948 ACNE 13 0.0002
949 CEREBROVASCULAR ACCIDENT 29 0.0002
950 UNDERDOSE 12 0.0002
951 HAEMORRHAGE 17 0.0002
952 DRUG DOSE OMISSION 26 0.0002
953 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
954 SURGERY 9 0.0002
955 NERVOUSNESS 8 0.0002
956 PARAESTHESIA 24 0.0002
957 IRRITABILITY 9 0.0001
958 PRODUCT QUALITY ISSUE 20 0.0001
959 COMA 7 0.0001
960 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
961 MEMORY IMPAIRMENT 20 0.0001
962 MYOCARDIAL INFARCTION 25 0.0001
963 ASTHMA 16 0.0001
964 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
965 EYE IRRITATION 8 0.0001
966 PRODUCT SUBSTITUTION ISSUE 8 0.0001
967 FEELING ABNORMAL 33 0.0001
968 CRYING 5 0.0001
969 ANGIOEDEMA 6 0.0001
970 CARDIAC DISORDER 12 0.0001
971 INTENTIONAL PRODUCT MISUSE 11 0.0001
972 MOBILITY DECREASED 9 0.0001
973 DYSKINESIA 5 0.0001
974 HOT FLUSH 9 0.0001
975 INCORRECT DOSE ADMINISTERED 27 0.0001
976 BLOOD GLUCOSE INCREASED 22 0.0001
977 MIGRAINE 10 0.0001
978 PRODUCT STORAGE ERROR 9 0.0001
979 OVERDOSE 22 0.0001
980 INJURY 7 0.0001
981 NO ADVERSE EVENT 18 0.0001
982 SUICIDE ATTEMPT 6 0.0001
983 SUICIDAL IDEATION 9 0.0001
984 DERMATITIS ATOPIC 5 0.0001
985 ALOPECIA 18 0.0001
986 FLUSHING 8 0.0001
987 INJECTION SITE HAEMORRHAGE 6 0.0001
988 INJECTION SITE PRURITUS 5 0.0001
989 MUSCULOSKELETAL STIFFNESS 6 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
991 INJECTION SITE ERYTHEMA 7 0.0001
992 INJECTION SITE PAIN 17 0.0001
993 RHEUMATOID ARTHRITIS 6 0.0001